• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EVOQUE TRICUSPID VALVE REPLACEMENT SYSTEM; PERCUTANEOUSLY DELIVERED PROSTHESES AND TRICUSPID VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EVOQUE TRICUSPID VALVE REPLACEMENT SYSTEM; PERCUTANEOUSLY DELIVERED PROSTHESES AND TRICUSPID VALVES Back to Search Results
Model Number 9850TDSUS
Medical Device Problem Code Difficult to Insert (1316)
Health Effect - Clinical Code Perforation of Vessels (2135)
Date of Event 11/04/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The manufacturer's investigation is ongoing and a follow-up report will be submitted when the investigation is complete.
 
Event or Problem Description
Edwards received notification of a transcatheter tricuspid valve replacement (ttvr) procedure involving the evoque system.The iliac vein was perforated upon delivery system (ds) insertion.A stent was placed in the vein.The procedure was aborted due to access difficulties.However, the patient is reported to be in stable condition.
 
Additional Manufacturer Narrative
The following sections were updated/corrected/added: b4, g3, g6, h2, h6, and h11.Additional type of investigation codes that were unable to be added in h6: analysis of images.Labelling review.The reported complaint for damage to vessel during insertion was confirmed with other empirical evidence via complaint description.The device history record review was completed, and this device passed all manufacturing and sterilization inspections.No nonconformances related to the complaint event were identified.The patient did not have any known anatomical variations and there was no difficulty inserting the delivery system that may have contributed to the iliac vein perforation.Imaging review of patient screening also confirmed no tortuosity observed based on the access route taken during the procedure.Available information suggests user manipulation of the delivery system as a potential contributing factor.However, a definitive root cause is unable to be established.Since no manufacturing non-conformances were found and no labeling, training, or ifu deficiencies were identified, no preventative or corrective actions were required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOQUE TRICUSPID VALVE REPLACEMENT SYSTEM
Common Device Name
PERCUTANEOUSLY DELIVERED PROSTHESES AND TRICUSPID VALVES
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
cassandra cook
1 edwards way
irvine, CA 92614
5743778277
MDR Report Key23596399
Report Number2015691-2025-09395
Device Sequence Number10291248
Product Code NPW
UDI-Device Identifier00690103217520
UDI-Public(01)00690103217520(17)260409(11)250409
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P230013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/09/2026
Device Model Number9850TDSUS
Device Lot Number66493227
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/04/2025
Supplement Date Received by Manufacturer12/09/2025
Initial Report FDA Received Date11/19/2025
Supplement Report FDA Received Date12/10/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/09/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age72 YR
Patient SexFemale
-
-